Daxor (DXR) Competitors $13.00 +0.30 (+2.36%) As of 03:29 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DXR vs. SI, NNOX, MGRM, TLSI, INGN, CVRX, CV, SKIN, ELMD, and NYXHShould you be buying Daxor stock or one of its competitors? The main competitors of Daxor include Shoulder Innovations (SI), Nano-X Imaging (NNOX), Monogram Orthopaedics (MGRM), TriSalus Life Sciences (TLSI), Inogen (INGN), CVRx (CVRX), CapsoVision (CV), Beauty Health (SKIN), Electromed (ELMD), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry. Daxor vs. Its Competitors Shoulder Innovations Nano-X Imaging Monogram Orthopaedics TriSalus Life Sciences Inogen CVRx CapsoVision Beauty Health Electromed Nyxoah Shoulder Innovations (NYSE:SI) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings. Do insiders & institutionals have more ownership in SI or DXR? 1.3% of Daxor shares are held by institutional investors. 1.7% of Shoulder Innovations shares are held by insiders. Comparatively, 59.5% of Daxor shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts rate SI or DXR? Shoulder Innovations currently has a consensus target price of $19.60, suggesting a potential upside of 58.32%. Daxor has a consensus target price of $25.00, suggesting a potential upside of 92.31%. Given Daxor's higher possible upside, analysts clearly believe Daxor is more favorable than Shoulder Innovations.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shoulder Innovations 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Daxor 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is SI or DXR more profitable? Company Net Margins Return on Equity Return on Assets Shoulder InnovationsN/A N/A N/A Daxor N/A N/A N/A Does the media favor SI or DXR? In the previous week, Shoulder Innovations and Shoulder Innovations both had 3 articles in the media. Daxor's average media sentiment score of 0.62 beat Shoulder Innovations' score of 0.34 indicating that Daxor is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shoulder Innovations 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Daxor 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is SI or DXR a better dividend stock? Shoulder Innovations pays an annual dividend of $2.9420 per share and has a dividend yield of 23.8%. Daxor pays an annual dividend of $0.03 per share and has a dividend yield of 0.2%. Shoulder Innovations pays out -9.8% of its earnings in the form of a dividend. Which has stronger earnings and valuation, SI or DXR? Daxor has lower revenue, but higher earnings than Shoulder Innovations. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShoulder Innovations$37.32M6.75-$609.99M-$29.96-0.41Daxor$3.31M18.99N/AN/AN/A SummaryShoulder Innovations and Daxor tied by winning 5 of the 10 factors compared between the two stocks. Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DXR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DXR vs. The Competition Export to ExcelMetricDaxorMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$62.88M$5.59B$6.13B$10.46BDividend YieldN/A1.26%5.73%4.78%P/E RatioN/A30.0285.0627.23Price / Sales18.99220.90573.27177.38Price / CashN/A27.8637.3961.86Price / BookN/A4.6412.386.64Net IncomeN/A$197.51M$3.32B$276.79M7 Day Performance2.12%1.35%-0.27%-1.54%1 Month Performance13.74%4.75%9.52%5.44%1 Year Performance42.23%23.76%71.62%36.30% Daxor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DXRDaxor3.7646 of 5 stars$13.00+2.4%$25.00+92.3%+41.1%$62.88M$3.31M0.0037Positive NewsSIShoulder Innovations3.1943 of 5 stars$12.86-1.9%$19.60+52.5%N/A$261.73MN/A-0.4361NNOXNano-X Imaging2.6515 of 5 stars$4.30+7.9%$8.50+97.9%-29.3%$248.17M$11.28M-4.77190Positive NewsMGRMMonogram Orthopaedics1.0577 of 5 stars$6.00flat$5.40-10.0%N/A$243.78M$370K-12.0028Positive NewsTLSITriSalus Life Sciences2.5644 of 5 stars$4.68-2.1%$10.90+132.9%+1.8%$233.39M$29.43M-3.97106News CoverageShort Interest ↑INGNInogen3.8555 of 5 stars$8.59flat$11.00+28.1%-7.9%$232.00M$335.70M-8.091,030Analyst ForecastCVRXCVRx2.4982 of 5 stars$8.92+2.2%$14.00+57.0%+20.0%$231.95M$51.29M-4.22160CVCapsoVisionN/A$4.66-1.1%$5.50+18.0%N/A$217.95MN/A0.0090Short Interest ↑SKINBeauty Health2.077 of 5 stars$1.69+2.1%$2.81+66.9%-8.6%$213.69M$334.30M-6.021,030ELMDElectromed3.9353 of 5 stars$25.00+1.5%$36.25+45.0%+9.4%$209.33M$64M33.32160NYXHNyxoah2.1012 of 5 stars$6.13-6.1%$15.00+144.9%-35.9%$208.62M$4.89M-2.66110 Related Companies and Tools Related Companies Shoulder Innovations Alternatives Nano-X Imaging Alternatives Monogram Orthopaedics Alternatives TriSalus Life Sciences Alternatives Inogen Alternatives CVRx Alternatives CapsoVision Alternatives Beauty Health Alternatives Electromed Alternatives Nyxoah Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DXR) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Daxor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
